Sangamo Therapeutics files Chapter 11 bankruptcy due to insolvency
Sangamo Therapeutics, Inc. has filed for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court for the District of Delaware, resulting in the appointment of an examiner to investigate claims by creditors.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed